MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
1.062
-0.034 (-3.10%)
Oct 22, 2026, 5:35 PM CEST

MaaT Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-34.31-31.06-28.9-19.72-13.71-9.02
Depreciation & Amortization
4.761.741.550.790.370.29
Other Amortization
--0.140.080.060.04
Stock-Based Compensation
1.061.671.530.870.650.79
Other Operating Activities
0.021.050.27-0.310.080.19
Change in Accounts Receivable
11.74-0.05-0.950.35-0.32-0.39
Change in Inventory
0.09-0.020.13-0.14-0.01-0.03
Change in Accounts Payable
1.912.992.481.842.041.07
Change in Other Net Operating Assets
-0.817.981.73-2.43-1.75-0.86
Operating Cash Flow
-15.54-15.72-22.04-18.67-12.61-7.93
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.45-0.61-0.75-1.09-0.66-0.24
Sale of Property, Plant & Equipment
00----
Investment in Securities
0.160.11-0.060.01-0.2-
Other Investing Activities
0.220.230.40.640.05-
Investing Cash Flow
-0.07-0.27-0.42-0.44-0.82-0.24

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-3.245.12-7.480.46
Long-Term Debt Repaid
--2.89-3.58-4.19-1.93-0.95
Net Debt Issued (Repaid)
9.450.351.54-4.195.55-0.49
Issuance of Common Stock
8.6620.8117.2612.590.132.44
Repurchase of Common Stock
-0.04-0.05--0.08-0.14-
Other Financing Activities
-0.39-0.42-0.47-0.18-0.15-0.1
Financing Cash Flow
17.6820.718.338.145.3631.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
-0-0-0-0-
Net Cash Flow
2.074.71-4.13-10.97-8.0623.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-16-16.33-22.79-19.76-13.27-8.17
Free Cash Flow Growth
------
Free Cash Flow Margin
-503.68%-360.88%-708.77%-887.03%-927.76%-840.23%
Free Cash Flow Per Share
-0.90-1.02-1.75-1.74-1.34-3.37
Levered Free Cash Flow
-3.46-14.16-12.25-11.13-8.04-4.99
Unlevered Free Cash Flow
-2.43-13.37-11.71-10.88-7.92-4.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.390.420.490.180.150.1
Change in Working Capital
12.9310.893.38-0.38-0.05-0.21